Heriot-Watt University Featured PhD Programmes
Ulster University Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Monash University Featured PhD Programmes
University of Glasgow Featured PhD Programmes
United Kingdom
Dundee×
10 miles

Cancer / Oncology PhD Projects, Programs & Scholarships in Dundee

We have 11 Cancer / Oncology PhD Projects, Programs & Scholarships in Dundee

  • Cancer / Oncology×
  • United Kingdom×
  • Dundee×
  • clear all
Order by 
Showing 1 to 10 of 11
  China Scholarship Council PhD Programme: How growth signals regulate replication licensing and cell division in normal and cancerous oesophageal cells
  Prof J Blow, Dr I Nathke, Prof R Petty
Application Deadline: 11 February 2019
In order to maintain genetic stability and prevent the amplification of chromosome segments, the process of DNA replication occurs in two strictly non-overlapping phases.
  MRC DTP 4 Year PhD Programme: Revealing dynamic and elusive early-mitotic events using state-of-the-art live-cell light sheet imaging
  Dr T Tanaka, Dr M MacDonald
Application Deadline: 18 January 2019
This project is part of our exciting and challenging University of Dundee 4-year MRC DTP Programme in Quantitative and Interdisciplinary approaches to biomedical science.
  MRC DTP 4 Year PhD Programame: Targeting protein degradation as an approach to inhibit oncogenes
  Dr G Sapkota, Prof A Ciulli
Application Deadline: 18 January 2019
This project is part of our exciting and challenging University of Dundee 4-year MRC DTP Programme in Quantitative and Interdisciplinary approaches to biomedical science.
  Enabling Precision Medicine through Oesophageal Cancer Proteogenomics
  Prof R Petty, Prof A I Lamond
Applications accepted all year round
Capitalising on technological advances in next generation sequencing, genomic landscaping projects have provided a comprehensive catalogue of genetic abnormalities in human cancer, and in some tumour types provided classifications useful for clinical decision making.
  Quantitative proteomic and cell biological analysis of TGF driven tumour promotion in melanoma and squamous cell cancers
  Dr G J Inman, Prof A I Lamond
Applications accepted all year round
Transforming growth factor- can act as both a potent tumour suppressor and tumour promoter in a context dependent manner.
  Precision Medicine for Squamous cell Carcinomas – NRF2/KEAP1 subtypes
  Prof A Dinkova-Kostova, Dr C Proby, Prof R Petty
Applications accepted all year round
Squamous cell carcinomas (SCCs), which arise at a variety of anatomical sites from stratified squamous epithelium, represent the most frequent human solid malignancies and are a major cause of cancer mortality.
  DNA Strategic Epigenetic Biomarkers in Melanoma
  Dr C Proby, Prof C N A Palmer
Applications accepted all year round
Hypothesis. That tumour-specific DNA methylation present in free circulating DNA from melanoma patients will enable early detection of disease relapse or metastasis facilitating life-preserving benefit from additional therapies such as immune checkpoint inhibitors.
  Precision Medicine: Using machine learning and classification methods to identify immune evasion signatures in high-risk malignancies
  Dr C Proby, Prof R Petty
Applications accepted all year round
Squamous cell carcinomas across multiple sites (lung, head and neck, skin, oesophagus) represent the most frequent human malignancies and are a major cause of cancer mortality with limited therapeutic options for advanced disease.
  Investigating phosphorylation-dephosphorylation dynamics during the cell cycle.
  Dr A Saurin
Applications accepted all year round
Protein phosphorylation is a critical post-translational modification needed for most biological responses. Although we have currently identified hundreds of thousands of different phosphorylation sites, we still lack one fundamental piece of information that is common to every single one of those sites.
  Establishing the potential of GSK3 manipulation for the treatment of human leukaemias
  Dr C Sutherland, Dr S Tauro
Applications accepted all year round
Background. Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.